People | June 08, 2022
Prolacta Bioscience appoints David Steinberg as CFO
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
The proposed demerger is the most significant corporate change for GSK in the last 20 years
The site, located in Berkeley County, will be operated using the same quality standards as DuPont’s Healthcare Industries Materials Site, the company’s longstanding biopharmaceutical manufacturing site in Hemlock, Michigan
The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction
Includes thermostabilized Ebola vaccines
Pharmapack Europe recognizes excellence and innovation from exhibitors across connected devices, sustainability, supply chain logistics, route of administration, and packaging innovation, as well from the wider industry for patient-centric design and eco-design
Subscribe To Our Newsletter & Stay Updated
